title: Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.
abstract: BACKGROUND
  Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa despite tools currently available for its control. Making malaria vaccine available for routine use will be a major hallmark, but its acceptance by community members and health professionals within the health system could pose considerable challenge as has been found with the introduction of polio vaccinations in parts of West Africa. Some of these challenges may not be expected since decisions people make are many a time driven by a complex myriad of perceptions. This paper reports knowledge and perceptions of community members in the Kintampo area of Ghana where malaria vaccine trials have been ongoing as part of the drive for the first-ever licensed malaria vaccine in the near future.
  
  
  METHODS
  Both qualitative and quantitative methods were used in the data collection processes. Women and men whose children were or were not involved in the malaria vaccine trial were invited to participate in focus group discussions (FGDs). Respondents, made up of heads of religious groupings in the study area, health care providers, traditional healers and traditional birth attendants, were also invited to participate in in-depth interviews (IDIs). A cross-sectional survey was conducted in communities where the malaria vaccine trial (Mal 047RTS,S) was carried out. In total, 12 FGDs, 15 IDIs and 466 household head interviews were conducted.
  
  
  RESULTS
  Knowledge about vaccines was widespread among participants. Respondents would like their children to be vaccinated against all childhood illnesses including malaria. Knowledge of the long existing routine vaccines was relatively high among respondents compared to hepatitis B and Haemophilus influenza type B vaccines that were introduced more recently in 2002. There was no clear religious belief or sociocultural practice that will serve as a possible barrier to the acceptance of a malaria vaccine.
  
  
  CONCLUSIONS
  With the assumption that a malaria vaccine will be as efficacious as other EPI vaccines, community members in Central Ghana will accept and prefer malaria vaccine to malaria drugs as a malaria control tool. Beliefs and cultural practices as barriers to the acceptance of malaria vaccine were virtually unknown in the communities surveyed.
authors: Kintampo Health Research Centre, Kintampo, Ghana. lawrence.febir@kintampo-hrc.org
authors: Lawrence G
authors: LG
authors: Febir
authors: Kwaku P
authors: KP
authors: Asante
authors: Dan-Bright S
authors: DB
authors: Dzorgbo
authors: Kojo A
authors: KA
authors: Senah
authors: Timothy S
authors: TS
authors: Letsa
authors: Seth
authors: S
authors: Owusu-Agyei
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D005869:Ghana / Q000453:epidemiology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007407:Interviews as Topic; D008288:Malaria / Q000453:epidemiology* / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D055815:Young Adult
chemical_list: D017780:Malaria Vaccines
references: N Engl J Med. 2012 Dec 13;367(24):2284-95
references: 23136909
references: Glob Health Action. 2012 Dec 20;5:1-11
references: 23273249
references: Acta Trop. 2006 May;98(2):111-7
references: 16647681
references: Trop Med Int Health. 2002 May;7(5):462-70
references: 12000657
references: N Engl J Med. 2011 Nov 17;365(20):1863-75
references: 22007715
references: Malar J. 2010 Nov 07;9:314
references: 21054895
references: BMC Public Health. 2010 Jul 12;10:409
references: 20624306
references: Lancet. 2007 Aug 11;370(9586):465-6
references: 17693161
references: N Engl J Med. 2013 Mar 21;368(12):1111-20
references: 23514288
references: Malar J. 2011 May 30;10:147
references: 21624117
references: Int J Epidemiol. 2006 Jun;35(3):691-704
references: 16507643
references: Malar J. 2009 Sep 28;8:220
references: 19785766
references: Emerg Infect Dis. 2008 May;14(5):716-9
references: 18439351
references: Malar J. 2012 Nov 28;11:394
references: 23186030
references: Nature. 2005 Mar 10;434(7030):214-7
references: 15759000
references: Med Microbiol Immunol. 2002 Oct;191(2):75-81
references: 12410345
references: Malar J. 2009 Nov 23;8:264
references: 19930654
references: Trop Med Int Health. 1996 Apr;1(2):147-54
references: 8665378
references: PLoS Med. 2007 Mar;4(3):e73
references: 17388657
references: PLoS One. 2009 Oct 02;4(10):e7302
references: 19806184
references: Trans R Soc Trop Med Hyg. 2010 Jul;104(7):496-503
references: 20417945
references: Insect Biochem Mol Biol. 2013 Apr;43(4):407-16
references: 23123179
references: Chin Med J (Engl). 2012 Feb;125(3):422-7
references: 22490396